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Results: From 1 day after vagal stimulation, concentrations of angiotensin II were
signiﬁcantly higher in the experimental group than those in the control group
(P<0.05). Stress induced a time-dependent decrease in AT1 expression and a time-
dependent increase in AT2 expression only in the apical portion of the myocardium.
Immunoﬂuorescent staining showed clear immunoreactivity for AT1 and AT2 in
scattered cells in the myocardium of basal and apical portions. From 3 days after vagal
stimulation, angiotensin (1-7) levels were signiﬁcantly lower in the experimental
group compared with the control group (P<0.05). Expression of ACE2 protein was
signiﬁcantly downregulated in the experimental group compared with the control
group from 3 days after vagal stimulation (P<0.05).
Conclusions: Expression of angiotensin II, its receptors, ACE-II and angiotensin (1-7)
was altered in response to SIC. The rennin-angiotensin system could represent a
therapeutic target in the prevention of SIC.
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Inhibition of dipeptyl peptidase-4 attenuates intimal hyperplasia following
arterial injury in rats
Xu Changwu, Chen Jing, Zhang Jing, Hu Qi, Hu Xiaorong, Lu Zhibing, Jiang Hong
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Objectives: Intimal hyperplasia is a major process of proliferative vascular disease,
including restenosis after angioplasty. Dipeptyl peptidase-4 (DPP-4) is a membrane-
bound exopeptidase which rapidly degrades glucagon-like peptide, and DPP-4 in-
hibitors are used for the treatment for type 2 diabetes mellitus. Recent studies showed
that soluble DPP-4 augmented cultured VSMCs proliferation and inhibition of DPP-4
suppressed the proliferation. This study was to explore the effect of a DPP-4 inhibitor,
sitagliptin, in the development of intimal hyperplasia after vascular injury.
Methods: Forty SD rats were randomly assigned into three groups, Sham group
(n¼10), Control group (n¼15) and Sitagliptin group (n¼15). Carotid artery balloon
injury model was performed in the Control and Sitagliptin groups. Rats in Sitagliptin
group were treated with sitagliptin (300 mg/kg/day) 3 days before the surgery and until
the day of sacriﬁce. The carotid arteries of rats were used for immunohistochemical
staining and morphometric analysis at 7 days and 28 days after balloon injury.
Results: Compared to the Control group, treatment of sitagliptin could signiﬁcantly
decrease the ratio of neointimal area to media area ratio by 15.7 % and 36.1 % at 7 days
and 28 days after balloon injury, respectively. Immunohistochemisty analyses showed
that there was less expression of proliferating cell nuclear antigen and NF-kB p65 in the
neointima 7 days after surgery in sitagliptin-treated rats. Moreover, the serum level of
8-iso-prostaglandin F2a in sitagliptin-treated rats was signiﬁcantly decreased.
Conclusions: Inhibition of DPP-4 attenuated neointimal formation after artery injury.
Therefore, inhibition of DPP-4 might represent a novel therapeutic strategy for
vascular injury.
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Genetic mutation of klotho induces salt-sensitive hypertension by CCR2 pathway
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Objectives: Klotho (KL) is identiﬁed as an anti-aging gene. Genetic mutation of KL in
mice results in accelerated aging syndrome. Hypertension is a common aging-related
disorder. An increase in salt sensitivity has also been noted with advancing age,
especially in hypertensive individuals. The aim of the present study is to investigate if
KL gene deﬁciency causes salt-sensitive hypertension and its mechanism.
Methods: One group of KL mutant heterozygous (+/-) mice and one group of wild
type (WT) mice were used to measure BP by tail-cuff method for 15 weeks. Then each
stain was divided into two sub-groups receiving high salt (HS) drinking or regular tap
water for 4 weeks. After that, each sub-group of each strain was further divided into
two mini-groups receiving INCB3284 (CCR2 antagonist) or vehicle for 10 days. BP
was continued to measure during treatment of HS and INCB3284. Blood, urine and
kidneys of all the 8 mini-groups were collected after the mice were sacriﬁced. Plasma
urea and urine creatinine level were detected with a quantichromTM assay kits. Urine
albumin concentration was measured with a microalbuminuria ELISA kit. HE and
Trichrome staining were performed in kidney sections for morphological examination.
Immunohistochemical staining was used to detect inﬂammatory cells (CD4, CD8, and
CD68) inﬁltration in kidneys. Western blotting was done to investigate the expression
of MCP-1, TNF-a, CCR2, MR, SGK1, NCC and ATP synthase b in kidneys.
Results: Systolic BP in KL (+/-) mice increased gradually and reached signiﬁcance
after the age of 16 weeks, showing KL gene deﬁciency caused spontaneous hyper-
tension. High salt (HS) intake further increased BP and exacerbated hypertension in
KL (+/-) mice, but did not affect BP in WT mice, indicating that KL deﬁciency elicited
salt-sensitive hypertension. Notably, the expression of MCP-1 and TNF-a, as well as
the inﬁltration of macrophages and T cells in kidneys was increased in KL (+/-) mice,
which were exacerbated by HS. Blockade of CC chemokine receptor 2 (CCR2), a
receptor of MCP-1, by a speciﬁc CCR2 antagonist (INCB3284) abolished the HS-
induced further increase of BP in KL (+/-) mice and the inﬁltration of macrophages
and T cells in kidneys of both KL (+/-) and KL (+/-) -HS mice. The results implied
that MCP-1/CCR2-mediated inﬂammation activation in kidneys induced by KL gene
deﬁciency contributed to the development of salt-sensitive hypertension. Moreover,
the expression of Sgk1, NCC and ATP synthase b were upregulated in kidneys of KL
(+/-) mice and further enhanced after HS loading, which also can be eliminated by
INCB3284. It suggested that CCR2-mediated inﬂammation activation in kidneysJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bresulted in Sgk1/NCC upregulation, even after HS, which may be one cause for salt
sensitivity. Additionally, blockade of CCR2 attenuated HS-induced renal structural
damage and functional impairment in KL (+/-) mice.
Conclusions: KL gene deﬁciency contributes to salt-sensitive hypertension via MCP-
1/CCR2-mediated inﬂammation activation in kidneys.
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The combination of transforming growth factor b1 and 5-azacytidine improve
the differentiation effects of rat Bone marrow mesenchymal stem cells into
cardiomyocytes
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Objectives: Bone marrow mesenchymal stem cells (BMMSCs) are used in cardiac
tissue engineering for regeneration of diseased hearts because they are relatively easy
to obtain from bone marrow tissue and can be differentiate into cardiomyocytes. In
this study, we examined the differentiation effects of rat BMMSCs into car-
diomyocyte-like cells by inducing with combination of transforming growth factor b1
(TGFb1) and 5-azacytidine (5-AZA).
Methods: BMMSCs were collected from the femur and tibial bone marrow of
4-week-old male Sprague-Dawley rats by density gradient centrifugation. The third
passage BMMSCs were divided into follow groups: the TGFb1 group, the 5-aza
group, the TGFb1 combined with 5-aza group, and the untreated group as control. The
effect of TGFb1 and 5-aza on BMMSC proliferation was measured by Non-
Radioactive Cell Proliferation Assay (MTS) at day 1, 3, 5, and 7 in vitro. The dif-
ferentiation rates and the apoptosis of induced BMMSCs were obtained by ﬂow
cytometry. The expressions of cardiac Troponin I (cTnI) and Connexin 43 (CX-43) in
the BMMSCs after four weeks of induction were detected by immunoﬂuorescence.
Results: The MTS assay showed that the TGFb1 combined with 5-aza group exhibit a
higher cell proliferation rate than the TGFb1 group and the 5-aza group. Flow
cytometry showed that the differentiation rate in TGFb1 combined with 5-aza group
was higher than that in TGFb1 group and 5-aza group. In addition, TGFb1 combined
with 5-aza ameliorated the apoptosis of induced BMMSCs. The expression levels of
cTnI and CX-43 in TGFb1 combined with 5-aza group were notably higher than those
in the TGFb1 group and the 5-aza group.
Conclusions: The combination of TGFb1 and 5-aza can improve the differentiation
effects of rat BMMSCs into cardiomyocyte-like cells and alleviate the cell damage
effects in vitro.
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Objectives: To observe the preventive effect of Tongxinluo capsule, a commonly
used angina-relief Chinese patent medicine, on micrangium spasm by porcine model
induced by neuropeptide Y (NPY). And to explore the mechanism of Tongxinluo
Capsule further in streptozotocin-induced diabetic rats (STZ-rats) and type 2 diabetic
Goto-Kakizaki (GK) rats.
Methods: (1) 14 miniature pigs were divided into Tongxinluo group and model group
randomly. After intragastric administration of Tongxinluo for 15d, NPY was injected
into the bloodstream in the middle of anterior descending artery through microcatheter.
Micrangium volume (a), ﬁlling rate (b) and microcirculation blood ﬂow (MBF) before
injection, 10min and 30min after injection was determined by myocardial contrast
echocardiography. The content of endothelin (ET-l) in serum in coronary artery was
determined by radioimmunoassay; (2) STZ-rats and GK rats were divided into Tong-
xinluo group, insulin group, diabetic model group and normal control group, and
intervenedwith corresponding drugs for 8weeks respectively. Left ventricle was stained
by HE, the basement membrane was stained by Hexamine silver and the density of
nuclear factor-kB (NF-kB) and collagen I, III and IV in left ventricle was assayed by
immunohistochemistry. The content of NF-kB, intercellular adhesion molecule-1
(ICAM-1), tumor necrosis factor-a (TNF-a), ET-1, angiotensin-II (Ang-II) and trans-
forming growth factor (TGF-b1) inmyocardial homogenateswas determined byELISA.
Results: (1) NPY induced porcine cardiac microvascular spasm model successfully,
which demonstrated decrease of a and MBF and increase of ET-1; Tongxinluo
maintained a, b and MBF at normal levels effectively, increased MBF signiﬁcantly at
30min after NPY injection, and decreased ET-1 levels, P<0.05, suggesting effectively
preventive efﬁcacy of Tongxinluo on NPY-induced porcine cardiac microvascular
spasm. (2) In both STZ-rats and GK rats, Tongxinluo relieved the myocardial
inﬂammation and diminished the content of vasoconstrictor substances, demonstrating
the decreased density of NF-kB in left ventricle (P <0.01) and the lowered content of
NF-kB, ICAM-1, TNF-a, ET-1 and Ang-II in myocardial homogenates (P<0.01-
0.05). (3) Tongxinluo thinned the thickness of myocardial basement membrane (P
<0.05), decreased the density of collagen IV (P <0.01) and improved the myocardial
morphology in left ventricle. (4) Tongxinluo decreased the density of collagen I and
improved that of collagen III (P<0.01-0.05), increased the content of TGF-b1asic and Translational Medicine C21
(P<0.01) and lowered collagen I/ III ratio (P <0.01), suggesting that Tongxinluo
improved myocardial collagen remodeling effectively.
Conclusions: Tongxinluo prevented NPY-induced cardiac microvascular spasm
effectively, and the mechanism was due to that Tongxinluo relieved the myocardial
inﬂammation, thinned the thickness of micrangium basement membrane and reversed
myocardial collagen remodeling.
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Objectives: The aim of this study was to investigate the changes of Urotensin II (UII)
and its receptor UT during myocardial ﬁbrosis in model of KK/Upj-Ay/J mice with
spontaneous type 2 diabetes, and evaluate whether blockade of UII would attenuate
cardiac ﬁbrosis in the model.
Methods: Diabetic KK/upj-AY/J and control C57BL/6J mice were fed with high fat
diet and normal chow diet respectively, for six weeks. Then, The KK/Upj - Ay/J mice
were randomly divided into two groups, diabetes mellitus (DM) group and diabetes +
urantide (DM + urantide) group, based on the level of fasting blood glucose. The DM
+ urantide mice were treated with urantide (30 mg kg-1day-1) by sc via an osmotic
mini-pump for 4 weeks. The water and food intake, weight were recorded. Fasting
blood glucose levels were assessed using blood collected from the tail vein.
Myocardial morphology was observed by Hematoxylin-Eosin and Masson staining.
The immunoreactivity of myocardial UII, UT, CD31, ﬁbroblast -speciﬁc protein
1 (FSP-1) were determined by immunohistochemistry. Plasma UII contents were
tested by radioimmunoassay. The protein expression of a-SMA, VE-cadherin and
P-smad2/3, CTGF were detected by western blot.
Results: There was a signiﬁcant increase in body weight, fasting blood glucose, water
intake and food intake in the DM group compared to the control group (P<0.01). The
DM group showed marked myocardial disarray and ﬁbrosis. Both UII and UT
immunoreactivity were increased in the DM group compared to the control group
(P<0.05). The ﬁbroblasts marker, FSP-1 immunoreactivity and a-SMA protein
expression were increased, while the endothelial marker, CD31 immunoreactivity and
VE-cadherin protein expression, were decreased, in the DM mice compared to control
mice (P<0.05). The smad2/3 Phosphorylation and CTGF protein expression in the
DM group were elevated than the controls (P<0.05). However, there is no signiﬁcant
difference in plasma UII levels between the DM and the controls (P>0.05). Impor-
tantly, treatment with Urantide signiﬁcantly reduced the body weight, fasting blood
glucose, water intake, and immunoreactivity of UII, UT, FSP-1, as well as protein
expression of a-SMA, P-samd2/3, CTGF, and alleviated myocardial disarray and
ﬁbrosis signiﬁcantly, while promoted CD31 immunoreactivity and VE-cadherin
expression signiﬁcantly (P<0.01 or P<0.05).
Conclusions: This study provided novel evidences that UII is involved in EndMT and
cardiac ﬁbrosis, and demonstrated that blockade of the UT receptor attenuated
myocardial ﬁbrosis in diabetes mellitus. It suggests that UII may represent a novel
therapeutic target in the treatment of diabetes mellitus.
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Omi/HtrA2 Cause Cardiomyocyte Apoptosis via Release of Cytochrome C
in Aging Rats
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Objectives: Existing studies have shown that the expression of Omi/HtrA2, a pro-
apoptosis protein, is increased in the aging heart, while the release of cytochrome c is
involved in apoptosis during aging. The relationship between the increased expression
of Omi/HtrA2 and the release of cytochrome c in apoptosis of the aging heart,
however, has not been investigated. The present study was designed to determine
whether or not the increased expression of Omi/HtrA2 causes cardiomyocyte
apoptosis during aging via the release of cytochrome c.
Methods: Aging myocardial tissues were collected from aging rats (20-24 months),
and expression of Omi/HtrA2 was determined by Western blot analysis. The activities
of caspase-3 and -9 were chosen to reﬂect the level of apoptosis. H9C2 cells, a rat
embryonic cardiomyocyte line with over-expressed mitochondrial Omi/HtrA2, were
constructed. Both real-time PCR and Western blot technologies were used to identify
stably transfected Omi/HtrA2 cells. Mitochondrial and cytosolic fractions were
extracted by differential centrifugation, and the cytochrome c level in cytosolic
fraction was detected by Western blot.
Results: The results showed that expression of Omi/HtrA2 and the activities of cas-
pase-3 and -9 were signiﬁcantly increased in aging myocardial issue. Moreover, the
activities of caspase-3 and -9 in over-expressed Omi/HtrA2 cells were elevated. The
release of cytochrome c was increased, which was reversed by the speciﬁc Omi/HtrA2
inhibitor, ucf-101.C22 JACC Vol 64/16/Suppl C j OctobConclusions: These results demonstrate that increased expression of Omi/HtrA2 in
aging cardiomyocytes promotes apoptosis via release of cytochrome c.
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overloaded rats via increasing phospholamban phosphorylation by activating
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Objectives: Relaxin is a peptide hormone with potent cardiovascular effects, which
has been demonstrated to be safe and effective in acute heart failure in clinic trials.
However, effect of relaxin on heart failure with preserved ejection fraction (HFpEF) is
unknown. The aims of the study were to determine whether relaxin could improve the
diastolic function of HFpEF and to investigate the underling mechanisms.
Methods: In the present study, adenoviral vector expression relaxin-2 (Ad-RLN-2)
and GFP (Ad-GFP) were constructed. Pressure-overloaded rat model was established
by performing trans-aortic constriction (TAC) on SD rats, and 4 weeks later, echo-
cardiography and cardiac hemodynamics were performed. These TAC rats were
randomly assigned into 3 groups (TAC control group, without intramyocardial in-
jection; TAC+Ad-RLN-2, with intramyocardial injection of Ad-RLN-2; TAC+Ad-
GFP, with intramyocardial injection of Ad-GFP). And 12 days after intramyocardial
injection, diastolic and systolic function were determined by echocardiography and
cardiac hemodynamics. And then the rats were sacriﬁced, proteins and RNA were
extracted from left ventricles; Western Blotting and quantitative real-time PCR were
performed. Neonatal cardiomyocytes were isolated and were cultured with Ad-RLN-2
and Ad-GFP. And then laser confocal was used to detect the intracellular location of
phosphorylation Akt and PLB in neonatal cardiomyocytes.
Results: RLN-2 gene therapy was demonstrated to improve diastolic function by
echocardiographic and hemodynamic parameters. E/A ratio signiﬁcantly increased in
rats with RLN-2 gene delivery (1.860.26 vs 1.540.32 and 1.520.21, P<0.05 ),
and meanwhile, tissue Doppler image early (e’) and late (a’) velocity ratio at septal
part (e’/a’) was almost normalized to 1.200.49 (P<0.001), IVRT was signiﬁcantly
reduced (37.785.80ms vs 47.017.07ms and 45.857.44ms, P¼0.008 and 0.027,
respectively), dP/dtmin was lowered (-59561104 vs -48641171 and -45831123,
P<0.05 for both comparison), and Tau was reduced (17.42.4 vs 26.12.7 and
24.83.1, P<0.05 for both comparison) in rats with RLN-2 gene delivery when
compared with the TAC control and TAC+Ad-GFP groups. In rats injected with
Ad-RLN-2, phosphorylation level of nuclear-targeted Akt and phospholamban were
elevated, and SERCA2 activity was increased without changing SERCA2 level.
Conclusions: RLN-2 gene therapy was demonstrated to improve diastolic function.
The potential mechanism may be that RLN-2 gene transfer increased SERCA2
activity by activating phospholamban phosphorylaiton at both Ser16 and Thr17 sites
via activating nuclear-targeted Akt phosphorylation without changing the SERCA2
level.
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Objectives: Arrhythmogenic right ventricular cardiomyopathy/Dysplasia (ARVC/D)
is a genetically determined disorder, characterized by the two components: cardio-
myopathy and arrhythmia. To date, the molecular pathogenesis underly this phe-
nomenon is poorly understood. Whether the ion channel defect involved in the
ARVC/D is unknown. The aim of this study was systematically evaluate the sodium
channel variants in ARVC/D.
Methods: The patients according to the diagnostic guideline of ARVC/D revised in
2010 were collected. Genomic DNA was extracted from peripheral blood lympho-
cytes. All the exons and exon-intron boundaries of the SCN5A gene and desmosomal
genes known to be associated with ARVC/D, including DSC2, DSG2, DSP, JUP and
PKP2 were sequenced through the direct DNA sequencing.
Results: A total of 13 unrelated index patients were collected. A new missense
heterozygote mutation I137M in SCN5A gene was found in one proband 5. The
mutation sited at the exon 4 of the SCN5A and the S1 segment in Domain I of
Nav1.5, consisted of an C-to-G substitution at nucleotide site 411 (c.411C>G), which
predicted a substitution of isoleucine for methionine at codon site 137 (P. Ile137Met,
I137M). I137M was not detected in the 400 healthy control chromosomes from in-
dividuals of the same ethnic background, which indicated that this mutation was a
conservative site in SCN5A gene and the encoding protein - Nav1.5 may have a
functional defect.
Conclusions: Our study for the ﬁrst time systematically evaluates the sodium channel
variants in patients with ARVC/D and ﬁnds a new SCN5A mutation - I137M. The
result increases the insight of genetic pathogenesis in ARVC/D. The mutational
sodium channel may destroy the “desmosomal-related complex” and cause the genesis
of ARVC/D.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
